Zobrazeno 1 - 10
of 61
pro vyhledávání: '"F K, Gorus"'
Autor:
Daniel Pipeleers, Zhidong Ling, L. Schoonjans, Georges Delvaux, F. K. Gorus, Marie Chintinne, Pieter Gillard, Daniel Jacobs-Tulleneers-Thevissen, Bart Keymeulen, Berit L. Strand
Publikováno v:
Diabetologia; Vol 56
Alginate-encapsulated human islet cell grafts have not been able to correct diabetes in humans, whereas free grafts have. This study examined in immunodeficient mice whether alginate-encapsulated graft function was inferior to that of free grafts of
Autor:
L Kaufman, Chantal Mathieu, Evy Vandemeulebroucke, Daniel Pipeleers, Herman Waldmann, Anette-G. Ziegler, Sophie Candon, U Van de Velde, Lucienne Chatenoud, Robert Hilbrands, Laurent Crenier, C De Block, Bart Keymeulen, M Walter, F. K. Gorus
Publikováno v:
Vrije Universiteit Brussel
Diabetologia
Diabetologia
AIMS/HYPOTHESIS: The aim of the study was to examine the 48 month outcome of treating recent-onset type 1 diabetic patients for 6 days with humanised CD3-antibody, ChAglyCD3. METHODS: Eighty patients, aged 12-39 years, were recruited for a phase 2 mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25660f81be5b020ec93b22bf5ee7fc08
https://doi.org/10.1007/s00125-009-1644-9
https://doi.org/10.1007/s00125-009-1644-9
Autor:
Chantal Mathieu, Werner A. Scherbaum, Johnny Ludvigsson, N. Hosszufalusi, Maria Nordwall, Nicholas J. Wareham, D. Mauricio, A. Barker, Thomas Mandrup-Poulsen, Angelo Lauria, B. Van der Schueren, F. K. Gorus, Ilse Weets, Richard David Leslie, Paolo Pozzilli, Nanette C. Schloot
ObjectiveBody weight-related insulin resistance probably plays a role in progression to type 1 diabetes, but has an uncertain impact following diagnosis. In this study, we investigated whether BMI measured at diagnosis was an independent predictor of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::192994200a7d9e754dd185d42f0fc275
https://hdl.handle.net/20.500.14017/0e86eccc-a02a-467e-b103-51d203514afa
https://hdl.handle.net/20.500.14017/0e86eccc-a02a-467e-b103-51d203514afa
Autor:
E. Vandemeulebroucke, P. De Pauw, F. K. Gorus, Ogonnaya C. Ubani, Rui Mao, I. Truyen, C. Van Schravendijk, K. Decochez, I Weets, Daniel Pipeleers, P. N. Jørgensen
Publikováno v:
Diabetologia. 48:2322-2329
AIMS/HYPOTHESIS: We investigated whether random proinsulin levels and proinsulin:C-peptide ratio (PI:C) complement immune and genetic markers for identifying relatives at high risk of type 1 diabetes. MATERIALS AND METHODS: During an initial sampling
Autor:
I Weets, M. Coeckelberghs, Z Laron, Eric Weber, L Kaufman, L Crenier, B. Van der Auwera, Daniel Pipeleers, R. Rooman, C De Block, Kristina Casteels, F. K. Gorus
Publikováno v:
Diabetologia
Type 1 diabetes arises from an interplay between environmental and genetic factors. The reported seasonality at diagnosis supports the hypothesis that currently unknown external triggers play a role in the onset of the disease. We investigated whethe
Publikováno v:
Acta Clinica Belgica. 59:1-13
Diabetes registries have documented that the lifetime risk of diabetes amounts to at least 10% in the western world. Moreover the prevalence of type 2 diabetes is increasing worldwide especially in developing countries. Furthermore there is a secular
Publikováno v:
Diabetologia. 45:1340-1343
Type I (insulin-dependent) diabetes mellitus results from an immune-mediated destruction of pancreatic beta cells for which HLA haplotypes DR3-DQ2 and DR4-DQ8 represent the strongest genetic risk markers. Mothers of patients with rheumatoid arthritis
Autor:
Geert A. Martens, J. Sadones, V. De Punt, C. Xavier, Katrijn Verhaeghen, Johannes M. F. G. Aerts, Olivier Costa, B. Brackeva, Gert Jan Kramer, F. K. Gorus, Geert Stangé
Publikováno v:
Journal of proteomics, 117, 156-167. Elsevier
Europe PubMed Central
Europe PubMed Central
There is a clinical need for plasma tests for real-time detection of beta cell destruction, as surrogate endpoint in islet transplantation and immunoprevention trials in type 1 diabetes. This study reports on the use of label-free LC-MS/MS proteomics
Autor:
Marius J. Giphart, Hanifi Moghaddam P, F. Schuit, Bart O. Roep, Albert Naipal, Van der Auwera B, F. K. Gorus, de Knijf P
Publikováno v:
Diabetes. 47:263-269
We analyzed 11 markers in the IDDM1 region in 120 IDDM patients and 83 healthy control subjects who were fully matched for the highest risk HLA-DQA1*0301-DQB1 *0302/DQA1*0501-DQB1*0201 genotype. Our study provides strong evidence that two regions in
Autor:
B. Van der Auwera, F. K. Gorus, Frans Schuit, Albert Naipal, Marius J. Giphart, Bart O. Roep, P. De Knijf, Payman Hanifi Moghaddam
Publikováno v:
Diabetes. 47:263-269
We analyzed 11 markers in the IDDM1 region in 120 IDDM patients and 83 healthy control subjects who were fully matched for the highest risk HLADQA1*O3O1-DQB1*O3O2/DQA1*O5O1-DQB1*O2O1 genotype. Our study provides strong evidence that two regions in th